Redox regulation of the tumor suppressor PTEN by glutaredoxin 5 and Ycp4

Biochemical and Biophysical Research Communications

Volumn 407, Issue 1, 2011, Pages 175-180

  Kim, Yujeong ^a   Chay, Kee Oh ^a   Kim, Inyoung ^a   Song, Yong Bhum ^b   Kim, Tae Youl ^b   Han, Seong Jeong ^c   Ahn, Younghee ^d   Cho, Seung Hyun ^e   Hoe, Kwang Lae ^f   Ahn, Bong Whan ^a   Huh, Won Ki ^b   Lee, Seung Rock ^a  

^a Chonnam National University Medical School   (South Korea)

^b Seoul National University   (South Korea)

^c Chonnam National University   (South Korea)

^d UNIVERSITY OF CALGARY   (Canada)

^e DE DUVE INSTITUTE   (Belgium)

^f Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Glutaredoxin 5; Glutathione; Hydrogen peroxide; PTEN; Ycp4

Indexed keywords

GLUTAREDOXIN; GLUTAREDOXIN 5; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; YCP4 PROTEIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME METABOLISM; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDOX STRESS; REDUCTION KINETICS; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; FLAVODOXIN; GLUTAREDOXINS; HUMANS; HYDROGEN PEROXIDE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PTEN PHOSPHOHYDROLASE; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

SACCHAROMYCES CEREVISIAE;

EID: 79953162809     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.133     Document Type: Article

References (29)

1. Kim R.H., Mak T.W. Tumours and tremors: how PTEN regulation underlies both. Br. J. Cancer 2006, 94:620-624.
2. Cid V.J., Rodriguez-Escudero I., Andres-Pons A., Roma-Mateo C., den A., den Hertog J., Molina M., Pulido R., Gil A. Assessment of PTEN tumor suppressor activity in nonmammalian models: the year of the yeast. Oncogene 2008, 27:5431-5442.
3. 2. J. Biol. Chem. 2002, 277:20336-20342.
4. Leslie N.R., Bennett D., Lindsay Y.E., Stewart H., Gray A., Downes C.P. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J. 2002, 22:5501-5510.
5. Kwon J., Lee S.R., Yang K.S., Ahn Y., Kim Y.J., Stadtman E.R., Rhee S.G. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. USA 2004, 101:16419-16424.
6. Seo J.H., Ahn Y., Lee S.R., Yeo C.Y., Hur K.C. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol. Biol. Cell 2005, 16:348-357.
7. 2 regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem. 2005, 280:16916-16924.
8. Yu C.X., Li S., Whorton A.R. Redox regulation of PTEN by S-nitrosothiols. Mol. Pharmacol. 2005, 68:847-854.
9. Pelicano H., Xu R.H., Du M., Feng L., Sasaki R., Carew J.S., Hu Y., Ramdas L., Hu L., Keating M.J., Zhang W., Plunkett W., Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J. Cell Biol. 2006, 175:913-923.
10. Cao J., Schulte J., Knight A., Leslie N.R., Zagozdzon A., Bronson R., Manevich Y., Beeson C., Neumann C.A. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 2009, 28:1505-1517.
11. Kim Y., Song Y.B., Kim T.Y., Kim I., Han S.J., Ahn Y., Cho S.H., Choi C.Y., Chay K.O., Yang S.Y., Ahn B.W., Huh W.K., Lee S.R. Redox regulation of the tumor suppressor PTEN by glutathione. FEBS Lett. 2010, 584:3550-3556.
12. Reed M.C., Thomas R.L., Pavisic J., James S.J., Ulrich C.M., Nijhout H.F. A mathematical model of glutathione metabolism. Theor. Biol. Med. Model. 2008, 5:8.
13. Wach A. PCR-synthesis of marker cassettes with long flanking homology regions for gene disruptions in S. cerevisiae. Yeast 1996, 12:259-265.
14. Sadowski I., Su P.C., Parent J. Disintegrator vectors for single-copy yeast chromosomal integration. Yeast 2007, 24:447-455.
15. Vilella F., Alves R., Rodriguez-Manzaneque M.T., Belli G., Swaminathan S., Sunnerhagen P., Herrero E. Evolution and cellular function of monothiol glutaredoxins: involvement in iron-sulphur cluster assembly. Comp. Funct. Genomics 2004, 5:328-341.
16. Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J. Biol. Chem. 2003, 278:50226-50233.
17. Davis D.A., Newcomb F.M., Starke D.W., Ott D.E., Mieyal J.J., Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol. Chem. 1997, 272:25935-25940.
18. Lind C., Gerdes R., Schuppe-Koistinen I., Cotgreave I.A. Studies on the mechanism of oxidative modification of human glyceraldehyde-3-phosphate dehydrogenase by glutathione: catalysis by glutaredoxin. Biochem. Biophys. Res. Commun. 1998, 247:481-486.
19. Bandyopadhyay S., Starke D.W., Mieyal J.J., Gronostajski R.M. Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of oxidation-inactivated nuclear factor I. J. Biol. Chem. 1998, 273:392-397.
20. 2. J. Biol. Chem. 2002, 277:46566-46575.
21. Landino L.M., Moynihan K.L., Todd J.V., Kennett K.L. Modulation of the redox state of tubulin by the glutathione/glutaredoxin reductase system. Biochem. Biophys. Res. Commun. 2004, 314:555-560.
22. Wang J., Tekle E., Oubrahim H., Mieyal J.J., Stadtman E.R., Chock P.B. Stable and controllable RNA interference: investigating the physiological function of glutathionylated actin. Proc. Natl. Acad. Sci. USA 2003, 100:5103-5106.
23. Adachi T., Pimentel D.R., Heibeck T., Hou X., Lee Y.J., Jiang B., Ido Y., Cohen R.A. S-Glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 2004, 279:29857-29862.
24. Lee S.R., Kwon K.S., Kim S.R., Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 1998, 273:15366-15372.
25. Johansson C., Lillig C.H., Holmgren A. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J. Biol. Chem. 2004, 279:7537-7543.
26. Rodriguez-Manzaneque M.T., Tamarit J., Belli G., Ros J., Herrero E. Grx5 is a mitochondrial glutaredoxin required for the activity of iron/sulfur enzymes. Mol. Biol. Cell 2002, 13:1109-1121.
27. Rodriguez-Manzaneque M.T., Ros J., Cabiscol E., Sorribas A., Herrero E. Grx5 glutaredoxin plays a central role in protection against protein oxidative damage in Saccharomyces cerevisiae. Mol. Cell. Biol. 1999, 19:8180-8190.
28. Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L., Weber G.J., Dooley K., Davidson A.J., Schmid B., Paw B.H., Shaw G.C., Kingsley P., Palis J., Schubert H., Chen O., Kaplan J., Zon L.I. Tubingen 2000 Screen Consortium, deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2000, 436(2005):1035-1039.
29. Ye H., Jeong S.Y., Ghosh M.C., Kovtunovych G., Silvestri L., Ortillo D., Uchida N., Tisdale J., Camaschella C., Rouault T.A. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J. Clin. Invest. 2010, 120:1749-1761.